부산대학교 도서관

Perrot, A; Facon, T; Plesner, T; Usmani, SZ; Kumar, S; Bahlis, NJ; Hulin, C; Orlowski, RZ; Nahi, H; Mollee, P

EUROPEAN JOURNAL OF HAEMATOLOGY. 114(5):883-889

Dimopoulos, MA; Oriol, A; Nahi, H; San-Miguel, J; Bahlis, NJ; Usmani, SZ; Rabin, N; Orlowski, RZ; Suzuki, K; Plesner, T

JOURNAL OF CLINICAL ONCOLOGY. 41(8):1590-1599

Moreau, P; Facon, T; Usmani, SZ; Bahlis, N; Raje, N; Plesner, T; Orlowski, RZ; Basu, S; Nahi, H; Hulin, C

LEUKEMIA. 39(3):710-719

Perrot, A; Facon, T; Plesner, T; Usmani, SZ; Kumar, S; Bahlis, NJ; Hulin, C; Orlowski, RZ; Nahi, H; Mollee, P

JOURNAL OF CLINICAL ONCOLOGY. 39(3):227-237

Facon, T; Kumar, SK; Plesner, T; Orlowski, RZ; Moreau, P; Bahlis, N; Basu, S; Nahi, H; Hulin, C; Quach, H

LANCET ONCOLOGY. 22(11):1582-1596

Facon, T; Kumar, S; Plesner, T; Orlowski, RZ; Moreau, P; Bahlis, N; Basu, S; Nahi, H; Hulin, C; Quach, H

NEW ENGLAND JOURNAL OF MEDICINE. 380(22):2104-2115

Haider AA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Division of Hematology/Oncology, University of Texas at Houston Health Science Center McGovern Medical School, Houston, TX, USA.; Marcoux C; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Smallbone P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mohamedi AH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Siddiqui UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ye C; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

Chohan KL; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gensini L; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Seif S; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Sun X; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Feng L; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Becnel MR; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Gaballa MM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Pasvolsky O; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ye JC; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Weber DM; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. sthomas@mdanderson.org.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: In Process; MEDLINE

Shishido SN; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA.; Mason J; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA.; Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.; Kamal M; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA.; Setayesh SM; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA.; Vora AU; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Berrios D; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Rueda LYM; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel K; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Manasanch EE; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kuhn P; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu.; Institute of Urology, Catherine & Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu.; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu.; Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu.; Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA, USA. PKuhn@usc.edu.; Department of Biological Sciences, Dornsife College of Letters, Arts, and Sciences, University of South-ern California, Los Angeles, CA, USA. PKuhn@usc.edu.

Publisher: Springer Nature Country of Publication: England NLM ID: 101708166 Publication Model: Electronic Cited Medium: Print ISSN: 2397-768X (Print) Linking ISSN: 2397768X NLM ISO Abbreviation: NPJ Precis Oncol Subsets: PubMed not MEDLINE

Facon, T; Kumar, SK; Plesner, T; Orlowski, RZ; Moreau, P; Bahlis, N; Basu, S; Nahi, H; Hulin, C; Quach, H

FUTURE ONCOLOGY. 19(13):887-895

Mery DE; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Tricot G; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Al Hadidi S; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Zhan Y; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Ashby C; Department of Biomedical Informatics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Bailey C; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Siegel ER; Department of Biostatistics, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Alapat DV; Department of Pathology, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Xu H; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Mattox S; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Schinke C; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Zangari M; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Thanendrarajan S; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Yi Q; Department of Oncology, Houston Methodist Cancer Center, Houston Methodist Hospital, Houston, TX, USA.; Orlowski RZ; Departments of Lymphoma/Myeloma, and of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; van Rhee F; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Shaughnessy JD; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.; Zhan F; Myeloma Center, Winthrop P. Rockefeller Institute, Department of Internal Medicine, College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA. fzhan@uams.edu.

Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: In Process; MEDLINE

Dimopoulos, MA; Oriol, A; Nahi, H; San-Miguel, J; Bahlis, NJ; Usmani, SZ; Rabin, N; Orlowski, RZ; Komarnicki, M; Suzuki, K

NEW ENGLAND JOURNAL OF MEDICINE. 375(14):1319-1331

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: PubMed not MEDLINE

Maura F; Memorial Sloan Kettering Cancer Center, New York, NY.; Bergsagel PL; Mayo Clinic, Scottsdale, AZ.; Ziccheddu B; Memorial Sloan Kettering Cancer Center, New York, NY.; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Kumar S; Mayo Clinic, Rochester, MN.; Maclachlan K; Memorial Sloan Kettering Cancer Center, New York, NY.; Derkach A; Memorial Sloan Kettering Cancer Center, New York, NY.; Garces JJ; Memorial Sloan Kettering Cancer Center, New York, NY.; Firestone R; Memorial Sloan Kettering Cancer Center, New York, NY.; Braggio E; Mayo Clinic, Scottsdale, AZ.; Asmann Y; Mayo Clinic, Scottsdale, AZ.; Durante M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Diamond BT; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Papadimitriou M; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Hultcrantz M; Memorial Sloan Kettering Cancer Center, New York, NY.; Marella A; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Castellano G; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Maeda A; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Lionetti M; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Matera A; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Pioggia S; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Da Vià MC; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; de Magistris C; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Leongamornlert D; Wellcome Sanger Institute, Hinxton, UK.; DeAvila D; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Sudalagunta PR; Department of Metabolism and Physiology, Moffitt Cancer Center, Tampa, FL.; Canevarolo RR; Department of Metabolism and Physiology, Moffitt Cancer Center, Tampa, FL.; Siegel EM; National Institutes of Health, Bethesda, MD.; Agius P; Aster Insights, Tampa, FL.; Teer J; Department of Biostatistics & Bioinformatics, Moffitt Cancer Center, Tampa, FL.; McPherson A; Memorial Sloan Kettering Cancer Center, New York, NY.; Yamashita Y; Mayo Clinic, Scottsdale, AZ.; Silva AS; Department of Metabolism and Physiology, Moffitt Cancer Center, Tampa, FL.; Blaney P; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY.; Baz R; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Patel KK; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer, Houston, TX.; Campbell P; Wellcome Sanger Institute, Hinxton, UK.; Morgan G; Myeloma Research Program, NYU Langone, Perlmutter Cancer Center, New York, NY.; Fonseca R; Mayo Clinic, Scottsdale, AZ.; Landgren O; Myeloma Institute, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Orlowski RZ; Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer, Houston, TX.; Shain KH; Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL.; Bolli N; Department of Oncology and Hemato-oncology, University of Milan, Milano, Italy.; Hematology Section, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy.; Usmani S; Memorial Sloan Kettering Cancer Center, New York, NY.; Rajkumar SV; Mayo Clinic, Rochester, MN.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Marcoux C; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Saeed A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Haider AA; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Hematology/Oncology, McGovern Medical School, The University of Texas, Health Sciences Center at Houston, Houston, Texas.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Irfan S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; YagoNieto; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: opasvolsky@mdanderson.org.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Marcoux C; Division of Hematology, Dalhousie University, Halifax, Canada.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haider AA; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Smallbone P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Mohamedi AH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Siddiqui UR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Jamil A; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Champlin RE; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. mqazilba@mdanderson.org.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE

Marcoux C; Division of Hematology, Dalhousie University, Halifax, Nova Scotia, Canada.; Pasyar S; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Khan HN; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Hematology/Oncology, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, Texas, USA.; Tanner MR; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Bashir Q; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Srour S; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Saini N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lin P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Ramdial J; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Nieto Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Neupane N; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Patel KK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Tang G; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Aljawai Y; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Kebriaei P; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Thomas SK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Shpall EJ; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Champlin R; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Qazilbash MH; Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Pasvolsky O; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: In Process; MEDLINE

Parker TL; Department of Medical Oncology and Hematology, Yale University School of Medicine, New Haven, CT.; Rosenthal A; SWOG Statistics and Data Management Center, Seattle, WA.; Sanchorawala V; Department of Hematology and Oncology, Boston University Medical Center, Boston, MA.; Landau HJ; Department of Hematological Malignancies, Memorial Sloan Kettering Cancer Center, New York, NY.; Campagnaro EL; Department of Hematology and Medical Oncology, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.; Kapoor P; Department of Hematology, Mayo Clinic, Rochester, MN.; Neparidze N; Department of Medical Oncology and Hematology, Yale University School of Medicine, New Haven, CT.; Girnius S; Department of Hematology and Medical Oncology, Carolina Community Outreach and Research Accrual/National Cancer Institute Community Oncology Research Program, Bethesda North Hospital/TriHealth, Montgomery, OH.; Hagen P; Department of Medical Oncology, Loyola University Medical Center, Maywood, IL.; Scott EC; Department of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR.; Hoering A; SWOG Statistics and Data Management Center, Seattle, WA.; Durie BGM; Department of Hematology/Oncology, Cedars-Sinai Medical Center, Los Angeles, CA.; Orlowski RZ; Division of Cancer Medicine, Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Kamal M; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Ange-les CA 90089, USA.; Shishido SN; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Ange-les CA 90089, USA.; Mason J; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Ange-les CA 90089, USA; Catherine & Joseph Aresty Department of Urology, Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles CA 90033, USA.; Patel K; Department of Lymphoma and Myeloma, USA.; Manasanch EE; Department of Lymphoma and Myeloma, USA.; Orlowski RZ; Department of Lymphoma and Myeloma, USA; Department of Experimental Therapeutics, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.; Kuhn P; Convergent Science Institute for Cancer, Michelson Center, University of Southern California, Los Ange-les CA 90089, USA; Catherine & Joseph Aresty Department of Urology, Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles CA 90033, USA; Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA; Department of Aerospace and Mechanical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, CA 90089, USA; Department of Biological Sciences, Dornsife College of Letters, Arts, and, Sciences, University of Southern California, Los Angeles, CA 90089, USA. Electronic address: pkuhn@usc.edu.

Publisher: Elsevier Country of Publication: United States NLM ID: 100886622 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5586 (Electronic) Linking ISSN: 14765586 NLM ISO Abbreviation: Neoplasia Subsets: In Process; MEDLINE

Lin P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Acharya S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Reyes-Silva F; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Basar R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Uprety N; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Moreno Rueda LY; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Lin P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Gilbert AL; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Banerjee PP; Baylor College of Medicine, Houston, Texas, United States.; Fang D; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Zhang C; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Nunez Cortes AK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Melo Garcia L; CHU de Québec-Université Laval, Quebec City, QC, Canada.; Daher M; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Muniz-Feliciano L; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Deyter GM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Woods V; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Rawal S; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Li P; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Jones CM; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Shrestha R; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Qazilbash MH; UT-MD Anderson Cancer Center, Houston, TX, United States.; Patel KK; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Lee HC; The University of Texas MD Anderson Cancer Center, Houston, United States.; Champlin RE; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Marin D; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Shpall EJ; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Orlowski RZ; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Rezvani K; The University of Texas MD Anderson Cancer Center, Houston, TX, United States.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101764786 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2643-3249 (Electronic) Linking ISSN: 26433230 NLM ISO Abbreviation: Blood Cancer Discov Subsets: MEDLINE